Fate Therapeutics, Inc. (FATE)
2.08
-0.09
(-4.15%)
USD |
NASDAQ |
Oct 30, 16:00
2.09
+0.01
(+0.48%)
After-Hours: 20:00
Fate Therapeutics Cash and Short Term Investments (Annual) : 203.66M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 203.66M |
| December 31, 2024 | 279.07M |
| December 31, 2023 | 315.18M |
| December 31, 2022 | 436.23M |
| December 31, 2021 | 615.91M |
| December 31, 2020 | 482.92M |
| December 31, 2019 | 221.43M |
| December 31, 2018 | 201.01M |
| Date | Value |
|---|---|
| December 31, 2017 | 100.95M |
| December 31, 2016 | 92.11M |
| December 31, 2015 | 64.81M |
| December 31, 2014 | 49.10M |
| December 31, 2013 | 54.04M |
| December 31, 2012 | 9.087M |
| December 31, 2011 | 6.387M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| AVITA Medical, Inc. | 18.18M |
| Agenus, Inc. | 2.998M |
| Amgen, Inc. | 9.129B |
| Anika Therapeutics, Inc. | 57.48M |
| BioCryst Pharmaceuticals, Inc. | 274.95M |